Methylmalonic Acid (MMA) Blood Test

What Does This Test Measure?

Methylmalonic acid is a small molecule produced during the breakdown of certain fatty acids and amino acids. Converting it onward requires an enzyme that depends on vitamin B12. When B12 is insufficient inside cells, that conversion stalls and methylmalonic acid accumulates.

This makes MMA a functional marker rather than a concentration measurement. Serum B12 tells you how much vitamin is circulating; MMA tells you whether cells actually have enough to do their work. The two can disagree, and when they do, MMA is generally the more reliable indicator.

That distinction matters because serum B12 has well-recognised limitations. Much of the measured B12 is bound to a protein that does not deliver it to tissues, and levels can appear normal in genuine deficiency, particularly in the borderline 200 to 400 pg/mL range where a large proportion of clinically significant deficiency hides.

Why Your Doctor Ordered This Test

The principal use is resolving a borderline serum B12. A value between roughly 200 and 400 pg/mL is genuinely ambiguous, and MMA settles whether tissue deficiency is present.

It is also used when clinical suspicion is high despite a normal B12 (unexplained macrocytosis, peripheral neuropathy, unsteady gait, cognitive change or glossitis) and in populations at elevated risk: older adults, vegans and vegetarians, people on long-term metformin or proton pump inhibitors, those with coeliac disease or Crohn's disease, and anyone after gastric or intestinal surgery.

It is also raised in the rare inherited disorders of methylmalonic acidaemia detected on newborn screening.

What High Methylmalonic Acid Means

A raised MMA with a low or borderline B12 indicates functional vitamin B12 deficiency, and it is the most reliable confirmation available. It reflects deficiency at the tissue level, which is what causes symptoms, and it rises earlier than haematological changes appear.

This matters clinically because B12 neurological damage can occur before anaemia develops, and it may become permanent if untreated. Waiting for a macrocytic anaemia before treating is a recognised way to miss the window.

The main confounder is kidney impairment, which raises MMA independently of B12 status through reduced clearance. In someone with a low eGFR, a raised MMA cannot be interpreted at face value, and homocysteine or a therapeutic trial of B12 may be more informative. Small bowel bacterial overgrowth also raises MMA through bacterial production, and volume depletion raises it modestly.

What Low Methylmalonic Acid Means

A low or normal MMA effectively excludes clinically significant B12 deficiency in someone with normal kidney function, and this is its most valuable use. A patient with a borderline serum B12 and a normal MMA does not have functional deficiency, and further B12 investigation or lifelong injections can reasonably be avoided.

A low MMA does not exclude folate deficiency, which is an important distinction. Folate deficiency raises homocysteine but leaves MMA normal, because the enzyme requiring B12 is not involved. Measuring both MMA and homocysteine therefore separates the two: raised MMA with raised homocysteine indicates B12 deficiency, while normal MMA with raised homocysteine points to folate.

A normal MMA during B12 treatment simply indicates the treatment is working and is the expected finding.

How to Prepare and What Affects the Result

Fasting is generally preferred, since a recent meal can modestly affect levels, though many laboratories accept a non-fasting sample. The test should ideally be taken before starting B12 supplementation, because treatment normalises MMA within days and destroys the diagnostic information.

Kidney function must be measured alongside, since impaired clearance raises MMA and is the commonest cause of a falsely positive result. Any B12 injections, high-dose oral B12, or multivitamin use in the preceding weeks should be declared, along with metformin, proton pump inhibitors and long-term antibiotics. Samples require prompt separation, as prolonged standing alters the result.

Common Misinterpretations

The most frequent error is interpreting a raised MMA in kidney disease as B12 deficiency. Reduced clearance alone raises it, and in someone with a low eGFR the result must be read with considerable caution.

The second is assuming a normal serum B12 excludes deficiency, which is the reason MMA exists as a test. A substantial proportion of genuine deficiency occurs with B12 values in the low-normal range, and MMA is what identifies it.

The third is testing after treatment has begun. B12 replacement normalises MMA within a few days, so a normal result in someone already supplementing tells you the treatment works, not whether they were deficient to begin with.

Frequently Asked Questions

Why measure MMA when B12 has already been tested?

Because serum B12 measures how much is circulating, not how much is reaching cells. Much of the measured B12 is bound to a protein that does not deliver it to tissues, so levels can look normal in genuine deficiency. MMA accumulates when cells lack functional B12, making it a truer reflection of tissue status, particularly in the ambiguous 200 to 400 pg/mL range.

Can kidney disease cause a high MMA?

Yes, and it is the main reason for a false positive. MMA is cleared by the kidneys, so reduced kidney function allows it to accumulate regardless of B12 status. Kidney function should always be checked alongside, and in significant impairment a raised MMA cannot be taken at face value.

How do MMA and homocysteine work together?

They separate B12 deficiency from folate deficiency. B12 deficiency raises both MMA and homocysteine. Folate deficiency raises homocysteine but leaves MMA normal, because the enzyme requiring B12 is not involved. Measuring both therefore identifies which vitamin is missing, which matters because treating the wrong one can allow neurological damage to progress.

Should I stop B12 supplements before this test?

Ideally the test is done before supplementation starts, because B12 replacement normalises MMA within days. If you are already taking B12, a normal result confirms the treatment is working but cannot tell you whether you were deficient originally. Discuss timing with your doctor rather than stopping treatment on your own.

Can B12 deficiency cause nerve damage without anaemia?

Yes, and this is why early detection matters. Neurological features (numbness, tingling, unsteadiness, cognitive change) can appear before any macrocytic anaemia develops, and prolonged deficiency can cause permanent damage. Waiting for anaemia before treating misses the window, which is one of the main arguments for using MMA when suspicion is high.

Related Markers: Read Together for Full Context

BloodWorker reads lab values together, not in isolation. These related markers provide essential context for interpreting your Methylmalonic Acid result: